Euda Health Holdings Limited(EUDA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 29 at 4:00 PM ET (Korea 10/30 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.16 | Insider Own | 41.17% | Shs Outstand | 24.8M | Perf Week | 15.94% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.8M | Perf Month | 8.39% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 0.09% | Perf Quarter | -19.69% |
| Income | -0.00B | P/S | 6.41 | EPS this Y | - | Inst Trans | - | Short Ratio | 0.06 | Perf Half Y | 6.68% |
| Sales | 0.01B | P/B | 7.77 | EPS next 5Y | - | ROA | -39.72% | Short Interest | 0.00M | Perf YTD | -66.45% |
| Book/sh | 2 | P/C | 125.26 | EPS past 3/5Y | 67.02% - | ROE | -208.62% | 52W High | -78.23% ($71.20) | Perf Year | -63.18% |
| Cash/sh | 0.12 | P/FCF | - | Sales past 3/5Y | -11.5% -8.35% | ROIC | -38.74% | 52W Low | 194.68% ($5.26) | Perf 3Y | 14.85% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 89.18% | Gross Margin | 47.57% | Volatility(W/M) | 12% 10.34% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 6.4 | Sales Y/Y TTM | - | Oper. Margin | -28.63% | ATR (14) | 1.59 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.53 | EPS Q/Q | -563.66% | Profit Margin | -32.69% | RSI (14) | 49.89 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.53 | Sales Q/Q | - | SMA20 | -3.19% ($16.01) | Beta | 0.59 | Target Price | $55 |
| Payout | - | Debt/Eq | 0.06 | Earnings | - | SMA50 | -0.25% ($15.54) | Rel Volume | 1.67 | Prev Close | $15.3 |
| Employees | 123 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | - | SMA200 | -6.06% ($16.5) | Avg Volume(3M) | 0.03M | Price | $15.5 |
| IPO | 2021/12/14 | Option/Short | No/Yes | Trades | 1400 | Volume | 45,000 | Change | 1.31% |
🩺 Yuda Health Holdings() is a Southeast Asian small-cap healthcare company based in Singapore, Malaysia, and China that provides a digital healthcare platform along with health and wellness services. Its portfolio combines an AI-powered patient triage and consultation system with wellness offerings such as bioenergy capsules, stem cell therapy, gene-editing research, and dietary supplements, positioning it as a microcap stock tied to the Southeast Asian health consumption theme.
Over the past 1 year, on the lower side
78% below its 1-year high.
Traded more than usual. That is 167% of its average volume.
EUDA has a sound balance sheet but weak earning power
Of every $100 in sales, $28.63 is lost.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $641. Peers typically go for $134.
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be +14.8%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 0.0%.
Tap to view numbers
It ranks #31 of 45 in the industry
Based on market cap of $46M.
STHO#28 Star Holdings $90M PER 6.1 
ASPS#29 Altisource Portfolio Solutions SA $61M PER - 
RFL#30 Rafael Holdings Inc $58M PER - EUDA#31 Euda Health Holdings Limited $46M PER - 
DUO#32 Fangdd Network Group Ltd $24M PER - 
FAQ
What kind of company is EUDA?
EUDA belongs to the Real Estate sector and operates in the Real Estate Services industry.
What is the market cap of EUDA?
The market cap of EUDA is approximately $46M, ranking 4,893 within its sector.
What is the 52-week high and low for EUDA?
EUDA has recorded a 52-week high of $71.20 and a low of $5.26.
